2021

  1. [Research Article]
    TW Kim, Y Kim, W Jung, DE Kim, H Keum, Y Son, S Jon, “Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells”, Journal of Controlled Release, Volume 331, 10 March 2021, Pages 74-84. (IF: 7.633)

2020

  1. [Review Article]
    Libor Vitek, M.D., Ph.D, and Claudio Tiribelli, M.D., Ph.D, “Bilirubin, Intestinal Integrity, the Microbiome, and Inflammation”, N ENGL J MED 383;7, August 13, 2020. (IF: 70.670)
  2. [Research Article]
    H Keum, TW Kim, Y Kim, C Seo, Y Son, J Kim, D Kim, W Jung, CH Whang, S Jon*, “Bilirubin nanomedicine alleviates psoriatic skin inflammation by reducing oxidative stress and suppressing pathogenic signaling”, Journal of Controlled Release, 2020, 325:359-369. (IF: 7.633)
  3. [Research Article]
    DY Lee, S Kang, Y Lee, JY Kim, D Yoo, W Jung, S Lee, YY Jeong, K Lee, S Jon*, “PEGylated Bilirubin-coated Iron Oxide Nanoparticles as a Biosensor for Magnetic Relaxation Switching-based ROS Detection in Whole Blood”, Theranostics, 2020, 10 (5). (IF: 8.712)

2019

  1. [Research Article]
    Y Lee, K Sugihara, MG Gillilland, S Jon, N Kamada, JJ Moon*, “Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis”, Nature Materials,19, 118-126. (IF: 38.887)

2018

  1. [Research Article]
    PAreek S, Zhang Mao, Trujillo-Ocampo A, Kim J, Jon S and Im JS, Bilirubin Nanoparticle as an anti-inflammatory therapy for graft versus host disease”, J Immunol. 1 May 2018, Vol. 200 (1 Supplement) (IF: 4.718)
  2. [Research Article]
    Lee S, Lee Y, Kim H, Lee DY and Jon S*, “Bilirubin Nanoparticle-Assisted Delivery of a Small Molecule-Drug Conjugate for Targeted Cancer Therapy”, Biomacromolecules. 2018; in press. (IF: 5.246) (Epub May 4)
  3. [Research Article]
    Lee Y, Lee S and Jon S*, “Biotinylated Bilirubin Nanoparticles as a Tumor Microenvironment-responsive Drug Delivery System for Targeted Cancer Therapy”, Adv. Science. 2018; in press. (IF: 9.034) (Epub April 24)

2017

  1. [Research Article]
    Lee DY, Kim JY, Lee S, Miao W, Kim HS, Min JJ and Jon S*, “Black pigment gallstone-inspired platinum-chelated bilirubin nanoparticles for combined photoacoustic imaging and photothermal therapy of cancers”, Angew. Chem. Int. Ed. 2017; 56(44): 13684-13688. (IF: 11.994) (Oct 23; Epub Sep 4)
  2. [Research Article]
    Kim DE,1 Lee Y,1 Kim M, Lee S, Jon S* and Lee SH*, “Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma”, Biomaterials 2017; 140, 37-44. (IF: 8.402) (Epub Jun 12) (1Equal contribution)
  3. [Research Article]
    Kim MJ, Lee Y, Jon S and Lee DY*, “PEGylated bilirubin nanoparticle as an anti-oxidative and anti-inflammatory demulcent in pancreatic islet xenotransplantation”, Biomaterials 2017; 133: 242-252. (IF: 8.402) (Jul, Epub Apr 18)
  4. [Research Article]
    Kim JY, Lee DY, Kang S, Miao W, Kim H, Lee Y and Jon S*, “Bilirubin nanoparticle preconditioning protects against hepatic ischemia-reperfusion injury”, Biomaterials 2017; 133: 1-10. (IF: 8.402) (Jul, Epub Apr 12)

2016

  1. [Research Article]
    Lee Y, Lee S, Lee DY, Yu B, Miao W and Jon S*, “Multi-stimul-responsive bilirubin nanoparticles for anticancer therapy”, Angew. Chem. Int. Ed. 2016: in press. (Selected as a Very Important Paper(VIP))
  2. [Research Article]
    Lee Y, Kim H, Kang S, Lee J, Park J and Jon S*, “Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy”, Angew. Chem. Int. Ed. 2016: 55(26), 7460-3. (IF: 11.709) (Jun 20)